2-amino-4,6-dimethyl pyrimidine has been researched along with Leishmaniasis, Cutaneous in 1 studies
*Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdala, H; Alvarez, N; Delmas, F; Di Giorgio, C; Le Baut, G; Le Pape, P; Robert, JM | 1 |
1 other study(ies) available for 2-amino-4,6-dimethyl pyrimidine and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
In vitro and in vivo antileishmanial activity of 2-amino-4,6-dimethylpyridine derivatives against Leishmania mexicana.
Topics: Animals; Antiprotozoal Agents; Flow Cytometry; Injections, Intraperitoneal; Leishmania mexicana; Leishmaniasis, Cutaneous; Lethal Dose 50; Liver; Lymph Nodes; Mice; Mice, Inbred BALB C; Pyrimidines; Spleen | 2002 |